OptiNose, Inc. (OPTN)
NASDAQ: OPTN · IEX Real-Time Price · USD
1.060
-0.020 (-1.85%)
At close: Jul 19, 2024, 4:30 PM
1.030
-0.030 (-2.83%)
Pre-market: Jul 22, 2024, 4:10 AM EDT
OptiNose Market Cap
OptiNose has a market cap or net worth of $153.53 million as of July 22, 2024. Its market cap has increased by 18.19% in one year.
Market Cap
153.53M
Enterprise Value
232.54M
1-Year Change
18.19%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since October 13, 2017, OptiNose's market cap has decreased from $672.30M to $153.53M, a decrease of -77.16%. That is a compound annual growth rate of -19.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 119.80M | -17.32% |
| Dec 29, 2023 | 144.90M | -6.21% |
| Dec 30, 2022 | 154.50M | 78.41% |
| Dec 31, 2021 | 86.60M | -59.83% |
| Dec 31, 2020 | 215.60M | -43.77% |
| Dec 31, 2019 | 383.40M | 50.00% |
| Dec 31, 2018 | 255.60M | -64.24% |
| Dec 29, 2017 | 714.80M | 6.32% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| scPharmaceuticals | 159.36M |
| Achieve Life Sciences | 159.00M |
| Context Therapeutics | 159.00M |
| Assertio Holdings | 156.00M |
| Rani Therapeutics Holdings | 155.29M |
| Vaxart | 153.51M |
| Kodiak Sciences | 150.78M |
| High Tide | 150.43M |